Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03930342 · ClinicalTrials.gov registry record · NA

Native-Changing High-risk Alcohol Use and Increasing Contraception Effectiveness Study

A NA study, sponsored by Washington State University.

Completed
Registry status
NA
Development phase
404
Enrollment target

NCT03930342: Completed NA study, sponsored by Washington State University.

NCT03930342 is a NA study that has completed, run by Washington State University. The registered enrollment target is 404 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03930342, a NA study, has completed, sponsored by Washington State University.

COMPLETED
Registry status
NA
Development phase
404 participants
Enrollment target

Study Summary

Native CHOICES is a randomized controlled trial of an adapted intervention to reduce the risk of alcohol exposed pregnancies in American Indians and Alaska Natives (AI/ANs). We will enroll 350 AI/AN women living on the Cheyenne River Sioux Indian Reservation or in Rapid City in South Dakota who are 18-44 years old, have risky drinking behaviors, are not currently pregnant but are able to become pregnant, and are sexually active but not using effective contraception.

Primary Outcome

Our primary outcome is measurement of change in risk of alcohol exposed pregnancy (AEP). Being at risk for an AEP is defined as engaging in heavy/binge drinking and ineffective contraception use in the 3 months prior to the final data collection session after exposure to the intervention. Count reflects number of participants who remained at risk for an AEP.

Interventions

  • BEHAVIORAL Native-CHOICES

Trial Details

FieldValue
Enrollment Target 404 participants
Start Date 2019-03-28
Est. Completion 2023-10-30
Phase NA
Washington State University

64 total trials

What the finished NCT03930342 record still lists

NCT03930342 is an interventional study that assigns participants to a tested intervention. The registered 404 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower).

The record links to 0 conditions, and to 1 intervention - of which Native-CHOICES is the first listed.

NCT03930342 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03930342 about?

NCT03930342 is a clinical study titled "Native-Changing High-risk Alcohol Use and Increasing Contraception Effectiveness Study". Native CHOICES is a randomized controlled trial of an adapted intervention to reduce the risk of alcohol exposed pregnancies in American Indians and Alaska Natives (AI/ANs). We will enroll 350 AI/AN women living on the Cheyenne River Sioux Indian Reservation or in Rapid City in South Dakota who are ...

What is the current status of trial NCT03930342?

This trial is currently completed. It is a NA study. The enrollment target is 404 participants. The study started on 2019-03-28. Estimated completion is 2023-10-30.

What interventions are being tested in trial NCT03930342?

The interventions under investigation include: Native-CHOICES (BEHAVIORAL).

Who is sponsoring clinical trial NCT03930342?

This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03930342's enrollment target sits among peer trials

404 244th of 2000 higher than 1,757 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05049057 · 404 participants · Phase 2

    Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI

  • NCT05611242 · 404 participants · Phase 3

    Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial

  • NCT06072612 · 404 participants · Phase 3

    Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

  • NCT05576350 · 405 participants · NA

    TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03930342, the US trial registry maintained by the National Library of Medicine. NCT03930342 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.